UK-based private equity firm Capital International has acquired 3% stake in Indian pharmaceutical company Intas Pharmaceuticals.

The stake was purchased from Mauritius-based private equity firm ChrysCapital for Rs6.9bn ($106.3m) consideration.

Apollo Capital has increased its stake in US-based biotechnology company GLG Pharma to 11.33% by acquiring an additional 7.5% stake.

The acquirer company is a private equity firm.